Authors' reply to 'RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group'

Affiliations

• ¹ Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Ehime, Japan.
• ² Department of Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
• ³ Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
• ⁴ Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
• ⁵ Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.